Web Results

J&J Wins U.S. Approval for First-in-Class Diabetes Drug - Bloomberg

www.bloomberg.com/news/articles/2013-03-29/jj-wins-u-s-approval-for-first-in-diabetes-drug-class

Mar 30, 2013 ... J&J Wins Approval for First in New Class of Diabetes Drugs. Johnson ... “I worry its use in women will be somewhat minimal,” Butler said.

UPDATED: J&J wins first FDA approval for new class of diabetes drug

www.fiercebiotech.com/r-d/updated-j-j-wins-first-fda-approval-for-new-class-of-diabetes-drug

Mar 29, 2013 ... The approval gives the healthcare giant its first market green light for a new ... UPDATED: J&J wins first FDA approval for new class of diabetes drug ... with a relatively high rate of genital infections which will limit uptake in our ...

FDA Approves Johnson Johnsons New Diabetes Drug

www.biospace.com/News/fda-approves-johnson-johnsons-new-diabetes-drug/291961

Apr 1, 2013 ... "Patients with type 2 diabetes struggle managing their blood sugar, and nearly half of ... Janssen will partner with other Johnson & Johnson companies focused on ..... (BIIB) Wins FDA Approval for Blockbuster Oral MS Drug.

Invokana Wins F.D.A. Approval for Diabetes Treatment - The New ...

www.nytimes.com/2013/03/30/business/invokana-wins-fda-approval-for-diabetes-treatment.html

Mar 29, 2013 ... The drug, Invokana, will be sold by Johnson & Johnson and treats patients with type 2 diabetes in a new way, by causing blood sugar to be ...

J&J faces big spending, big rivals for new diabetes drug Invokana ...

www.fiercepharma.com/sales-and-marketing/j-j-faces-big-spending-big-rivals-for-new-diabetes-drug-invokana

Apr 1, 2013 ... And J&J ($JNJ) will have to spend a pretty penny on detailing and advertising to ... And it's true that diabetes patients often have to change meds to keep control of ... J&J wins first FDA approval for new class of diabetes drug

FDA approves Johnson & Johnson diabetes drug, canagliflozin ...

www.reuters.com/article/us-usa-johnsonandjohnson-diabetes-idUSBRE92S0EY20130329

Mar 29, 2013 ... FDA has approved a new diabetes drug from Johnson & Johnson, making it the first in its class to be approved in the United States. The U.S. ...

Johnson & Johnson, Viacyte testing possible diabetes cure | Fox News

www.foxnews.com/health/2016/02/04/johnson-johnson-viacyte-testing-possible-diabetes-cure.html

Feb 4, 2016 ... Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, ... "We wanted to hedge our bets to make sure we would win in this space ... Further testing may be needed before the product can be approved by regulators. .... Does anyone for a second think that ANY socialized medicine nation or ...

Invokana - Uses, Side Effects and Dangerous Medical ... - Drug Center

www.drugcenter.com/drugs/invokana/

Oct 14, 2016 ... Most type 2 diabetes drugs manipulate insulin levels, which could lead to complications ... Johnson & Johnson, the manufacturer of Invokana, received approval for the drug from the FDA in 2013. ... How does Invokana work? ... It's important to keep track of your blood sugar levels and know the symptoms of ....

FDA OKs Janssen's Ivokana for Diabetes | Medpage Today

www.medpagetoday.com/endocrinology/diabetes/38161

Mar 29, 2013 ... Jardiance Wins CV Prevention Indication ... The drug is the only compound approved for diabetes that does not have an effect on insulin. ... However, drugmaker Janssen Pharmaceuticals, a Johnson & Johnson company, will have to conduct ... in patients who have increased ketones in their blood or urine.

3 Drugs Johnson & Johnson's Investors Better Know About

www.slideshare.net/TheMotleyFool/3-drugs-johnsons-investors-better-know-about

Apr 17, 2014 ... Johnson and Johnson's (JNJ) sales grew 3.5% in the past year, but only because ... Diabetes • Invokana – The first SGLT2 inhibitor to win FDA approval, .... Johnson's investors will need to keep close tabs on these 3 drugs this year. ... Merck, Pfizer, and Eli Lilly are also conducting phase 3 trials of their ow...

More Info

Johnson & Johnson's New Diabetes Drug: A Blockbuster in the ...

www.fool.com

Apr 21, 2014 ... Johnson's Invokana is about to face a host of new SGLT2 competitors ... Since Invokana helped lift Johnson's first-quarter sales in the U.S. last quarter, let's look at its ... Express Scripts expects spending on diabetes treatment will grow 11% in ... the first in a new class of diabetes drugs to win FDA ap...

FDA Approves First in New Class of Diabetes Drugs - Invokana

www.drugwatch.com

Apr 5, 2013 ... The FDA has approved Invokana (canagliflozin), the first drug in a new class of ... As the first company to win FDA approval, Johnson & Johnson has a leg up on industry rivals developing their own ... More details on the studies will be presented at the American Diabetes Association annual meeting in June.

Johnson & Johnson Could Tap The Huge Diabetes Market With ...

www.forbes.com

Mar 8, 2013 ... Johnson & Johnson has been battling with patent cliffs like many in the industry, ... Owing to these factors, the global diabetes drug market has seen rapid growth ... What limits the revenue potential of the drug is its lower efficacy in patients with impaired kidney functions. ... If Trump Does This, We Will Win ...